Back
Recursion Pharmaceuticals Stock Price Chart
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
27
RXRX
Recursion Pharmaceuticals
Last Price:
$4.30
Seasonality Move:
45.49%
7 Day Trial
ALL ACCESS PASS
$
7
FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RXRX is experiencing selling pressure, which indicates risk of future bearish movement.
Recursion Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.41 | Sell |
| 20-day SMA: | 5.13 | Sell |
| 50-day SMA: | 5.52 | Sell |
| 200-day SMA: | 6.68 | Sell |
| 8-day EMA: | 4.57 | Sell |
| 20-day EMA: | 4.94 | Sell |
| 50-day EMA: | 5.57 | Sell |
| 200-day EMA: | 6.76 | Sell |
Recursion Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.36 | Sell |
| Relative Strength Index (14 RSI): | 37.9 | Sell |
| Chaikin Money Flow: | -19311694 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.55 - 5.73) | Sell |
| Bollinger Bands (100): | (5.14 - 7.94) | Sell |
Recursion Pharmaceuticals Technical Analysis
| May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Recursion Pharmaceuticals Stock
Is Recursion Pharmaceuticals Stock a Buy?
-
Recursion Pharmaceuticals share price is 4.31 while RXRX 8-day simple moving average is 4.41, which is a Sell signal.
-
The stock price of RXRX is 4.31 while Recursion Pharmaceuticals 20-day SMA is 5.13, which makes it a Sell.
-
Recursion Pharmaceuticals 50-day simple moving average is 5.52 while RXRX share price is 4.31, making it a Sell technically.
-
RXRX stock price is 4.31 and Recursion Pharmaceuticals 200-day simple moving average is 6.68, creating a Sell signal.
RXRX Technical Analysis vs Fundamental Analysis
Sell
27
Recursion Pharmaceuticals (RXRX)
is a Sell
Is Recursion Pharmaceuticals a Buy or a Sell?
-
Recursion Pharmaceuticals stock is rated a SellThe current Recursion Pharmaceuticals [RXRX] share price is $4.31. The Score for RXRX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Recursion Pharmaceuticals Stock Info
Market Cap:
1.8B
Price in USD:
4.31
Share Volume:
22.4M
Recursion Pharmaceuticals 52-Week Range
52-Week High:
12.36
52-Week Low:
3.79
Sell
27
Recursion Pharmaceuticals (RXRX)
is a Sell
Recursion Pharmaceuticals Share Price Forecast
-
What is the Recursion Pharmaceuticals stock price today?The Recursion Pharmaceuticals stock price is 4.31 USD today.
-
Will RXRX stock go up or go down?Recursion Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Recursion Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Recursion Pharmaceuticals is overvalued.
Is Recursion Pharmaceuticals Stock a Buy?
-
Recursion Pharmaceuticals share price is 4.31 while RXRX 8-day exponential moving average is 4.57, which is a Sell signal.
-
The stock price of RXRX is 4.31 while Recursion Pharmaceuticals 20-day EMA is 4.94, which makes it a Sell.
-
Recursion Pharmaceuticals 50-day exponential moving average is 5.57 while RXRX share price is 4.31, making it a Sell technically.
-
RXRX stock price is 4.31 and Recursion Pharmaceuticals 200-day simple moving average is 6.76, creating a Sell signal.
Fundamental Analysis of Recursion Pharmaceuticals
Is Recursion Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.25 per share.
Technical Analysis of Recursion Pharmaceuticals
Should I short Recursion Pharmaceuticals stock?
-
RXRX Moving Average Covergence Divergence (MACD) indicator is -0.36, suggesting Recursion Pharmaceuticals is a Sell
-
Recursion Pharmaceuticals Relative Strength Index (RSI) is 37.9, which suggest Recursion Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Recursion Pharmaceuticals is (4.55 - 5.73), which suggest Recursion Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Recursion Pharmaceuticals is (5.14 - 7.94), which suggest Recursion Pharmaceuticals is a Sell
* Recursion Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.